Literature DB >> 20203056

Structure analysis of the two-peptide bacteriocin lactococcin G by introducing D-amino acid residues.

Camilla Oppegård1, Per Rogne1, Per Eugen Kristiansen1, Jon Nissen-Meyer1.   

Abstract

The importance of 3D structuring in the N- and C-terminal ends of the two peptides (39-mer LcnG-alpha and 35-mer LcnG-beta) that constitute the two-peptide bacteriocin lactococcin G was analysed by replacing residues in the end regions with the corresponding D-isomeric residues. When assayed for antibacterial activity in combination with the complementary wild-type peptide, LcnG-alpha with four D-residues in its C-terminal region and LcnG-beta with four d-residues in either its N- or its C-terminal region were relatively active (two- to 20-fold reduction in activity). 3D structuring of the C-terminal region in LcnG-alpha and the C- and N-terminal regions in LcnG-beta is thus not particularly critical for retaining antibacterial activity, indicating that the 3D structure of these regions is not vital for interpeptide interactions or for interactions between the peptides and cellular components. The 3D structure of the N-terminal region in LcnG-alpha may be more important, as LcnG-alpha with four N-terminal D-residues was the least active of these four peptides (10- to 100-fold reduction in activity). The results are consistent with a proposed structural model of lactococcin G in which LcnG-alpha and -beta form a transmembrane parallel helix-helix structure involving approximately 20 residues in each peptide, starting near the N terminus of LcnG-alpha and at about residue 13 in LcnG-beta. Upon expressing the lactococcin G immunity protein, sensitive target cells became resistant to all of these D-residue-containing peptides. The end regions of the two lactococcin G peptides are consequently not involved in essential structure-dependent interactions with the immunity protein. The relatively high activity of most of the D-residue-containing peptides suggests that bacteriocins with increased resistance to exopeptidases may be generated by replacing their N- and C-terminal residues with d-residues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20203056     DOI: 10.1099/mic.0.038430-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  8 in total

1.  Defining the structure and receptor binding domain of the leaderless bacteriocin LsbB.

Authors:  Kirill V Ovchinnikov; Per E Kristiansen; Gordana Uzelac; Ljubisa Topisirovic; Milan Kojic; Jon Nissen-Meyer; Ingolf F Nes; Dzung B Diep
Journal:  J Biol Chem       Date:  2014-07-03       Impact factor: 5.157

2.  LsbB Bacteriocin Interacts with the Third Transmembrane Domain of the YvjB Receptor.

Authors:  Marija Miljkovic; Gordana Uzelac; Nemanja Mirkovic; Giulia Devescovi; Dzung B Diep; Vittorio Venturi; Milan Kojic
Journal:  Appl Environ Microbiol       Date:  2016-08-15       Impact factor: 4.792

3.  Development of Class IIa Bacteriocins as Therapeutic Agents.

Authors:  Christopher T Lohans; John C Vederas
Journal:  Int J Microbiol       Date:  2011-11-30

Review 4.  Lactic Acid Bacteria and Their Bacteriocins: Classification, Biosynthesis and Applications against Uropathogens: A Mini-Review.

Authors:  Mduduzi Paul Mokoena
Journal:  Molecules       Date:  2017-07-26       Impact factor: 4.411

Review 5.  Applications of Lactic Acid Bacteria and Their Bacteriocins against Food Spoilage Microorganisms and Foodborne Pathogens.

Authors:  Mduduzi P Mokoena; Cornelius A Omatola; Ademola O Olaniran
Journal:  Molecules       Date:  2021-11-22       Impact factor: 4.411

Review 6.  Strategies for Biocontrol of Listeria monocytogenes Using Lactic Acid Bacteria and Their Metabolites in Ready-to-Eat Meat- and Dairy-Ripened Products.

Authors:  Irene Martín; Alicia Rodríguez; Josué Delgado; Juan J Córdoba
Journal:  Foods       Date:  2022-02-14

Review 7.  Bacteriocins as Potential Anticancer Agents.

Authors:  Sumanpreet Kaur; Sukhraj Kaur
Journal:  Front Pharmacol       Date:  2015-11-10       Impact factor: 5.810

Review 8.  Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile?

Authors:  Elaine Meade; Mark Anthony Slattery; Mary Garvey
Journal:  Antibiotics (Basel)       Date:  2020-01-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.